Dear Readers, Welcome to ADRENORECEPTOR ACTIVATING DRUGS Objective Questions and Answers have been designed specially to get you acquainted with the nature of questions you may encounter during your Job interview for the subject of ADRENORECEPTOR ACTIVATING DRUGS Multiple choice Questions. These Objective type ADRENORECEPTOR ACTIVATING DRUGS Questions are very important for campus placement test and job interviews. As per my experience good interviewers hardly plan to ask any particular question during your Job interview and these model questions are asked in the online technical test and interview of many Medical Industry.
a) Release of norepinephrine from nerve terminals
b) Activation of adrenoreceptors on postsynaptic sites
c) Release of epinephrine from the adrenal medulla
d) All of the above
a) It is synthesized into the adrenal medulla
b) It is synthesized into the nerve ending
c) It is transported in the blood to target tissues
d) It directly interacts with and activates adrenoreceptors
a) Epinephrine
b) Norepinephrine
c) Ephedrine
d) Methoxamine
a) Displacement of stored catecholamines from the adrenergic nerve ending
b) Inhibition of reuptake of catecholamines already released
c) Interaction with adrenoreceptors
d) Inhibition of the release of endogenous catecholamines from peripheral adrenergic neurons
a) Ephedrine
b) Epinephrine
c) Isoprenaline
d) Norepinephrine
a) a1 receptor
b) a2 receptor
c) beta1 receptor
d) beta2 receptor
a) ALFA receptors increase arterial resistence, whereas beta2 receptor promote smooth muscle relaxation
b) The skin and splanchic vessels have predominantly alfa receptors
c) Vessels in a skeletal muscle may constrict or dilate depending on whether alfa or beta2 receptors are activated
d) Skeletal muscle vessels have predominantly alfa receptors and constrict in the presence of epinephrine and norepinephrine
a) Alfa1 receptor
b) Alfa2 receptor
c) Beta1 receptor
d) Beta2 receptor
a) Bronchodilation
b) Vasodilatation
c) Tachycardia
d) Bradycardia
a) Heart
b) Blood vessels
c) Prostate
d) Pupillary dilator muscle
a) Bronchial muscles
b) Heart
c) Pupillary dilator muscle
d) Fat cells
a) Blood vessels
b) Intestine
c) Uterus
d) Bronchial muscles
a) The heart
b) The peripheral resistance
c) The venous return
d) All of the above
a) Increase peripheral arterial resistance
b) Increase venous return
c) Has no effect on blood vessels
d) Reflex bradycardia
a) Increase cardiac output
b) Increase peripheral arterial resistance
c) Decrease peripheral arterial resistance
d) Decrease the mean pressure
a) ?lfa agonists cause miosis
b) ?lfa agonists cause mydriasis
c) Beta antagonists decrease the production of aqueous humor
d) ?lfa agonists increase the outflow of aqueous humor from the eye
a) ?lfa1 receptor
b) ?lfa2 receptor
c) Beta 1 receptor
d) Beta 2 receptor
a) Epinephrine
b) Isoproterenol
c) Methoxamine
d) Dobutamine
a) Isoprenaline
b) Terbutaline
c) Xylometazoline
d) Methoxamine
a) Relaxation of gastrointestinal smooth muscle
b) Contraction of bladder base, uterus and prostate
c) Stimulation of insulin secretion
d) Stimulation of platelet aggregation
a) Increase in contractility
b) Bronchodilation
c) Tachycardia
d) Increase in conduction velocity in the atrioventricular node
a) Stimulation of renin secretion
b) Fall of potassium concentration in plasma
c) Relaxation of bladder, uterus
d) Tachycardia
a) Gluconeogenesis (beta2)
b) Inhibition of insulin secretion (alfa)
c) Stimulation of glycogenolysis (beta2)
d) All of the above
a) Lipolysis
b) Decrease in platelet aggregation
c) Bronchodilation
d) Tachycardia
a) Epinephrine acts on both alfa- and beta-receptors
b) Norepinephrine has a predominantly beta action
c) Methoxamine has a predominantly alfa action
d) Isoprenaline has a predominantly beta action
a) Norepinephrine
b) Methoxamine
c) Isoproterenol
d) Ephedrine
a) Methoxamine
b) Albuterol
c) Epinephrine
d) Norepinephrine
a) Isoproterenol
b) Ephedrine
c) Dobutamine
d) Norepinephrine
a) Norepinephrine
b) Methoxamine
c) Ritodrine
d) Ephedrine
a) Xylometazoline
b) Epinephrine
c) Dobutamine
d) Methoxamine
a) Norepinephrine
b) Terbutaline
c) Isoproterenol
d) Dobutamine
a) Isoproterenol
b) Dobutamine
c) Metaproterenol
d) Epinephrine
a) Terbutaline
b) Xylometazoline
c) Isoproterenol
d) Dobutamine
a) Epinephrine
b) Phenylephrine
c) Ephedrine
d) Isoproterenol
a) Positive inotropic and chronotropic actions on the heart (beta1 receptor)
b) Increase peripheral resistance (alfa receptor)
c) Predominance of alfa effects at low concentration
d) Skeletal muscle blood vessel dilatation (beta2 receptor)
a) Decrease in oxygen consumption
b) Bronchodilation
c) Hyperglycemia
d) Mydriasis
a) Bronchospasm
b) Anaphylactic shock
c) Cardiac arrhythmias
d) Open-angle glaucoma
a) Similar effects on beta1 receptors in the heart and similar potency at an alfa receptor
b) Decrease the mean pressure below normal before returning to the control value
c) Significant tissue necrosis if injected subcutaneously
d) Increase both diastolic and systolic blood pressure
a) Vasoconstriction
b) Vasodilatation
c) Bronchodilation
d) Decresed potassium concentration in the plasma
a) Epinephrine
b) Norepinephrine
c) Phenylephrine
d) Ephedrine
a) It is a direct-acting alfa1-receptor agonist
b) It increases heart rate, contractility and cardiac output
c) It causes reflex bradycardia
d) It increases total peripheral resistance
a) Xylometazoline
b) Phenylephrine
c) Methoxamine
d) Epinephrine
a) Methoxamine
b) Phenylephrine
c) Xylometazoline
d) Isoproterenol
a) Both an alfa- and beta-receptor agonist
b) beta1-selective agonist
c) beta2-selective agonist
d) Nonselective beta receptor agonist
a) Increase in cardiac output
b) Fall in diastolic and mean arterial pressure
c) Bronchoconstriction
d) Tachycardia
a) It is a relatively beta1-selective synthetic catecholamine
b) It is used to treat bronchospasm
c) It increases atrioventricular conduction
d) It causes minimal changes in heart rate and systolic pressure
a) It is a potent selective beta2 agonist
b) It causes uterine relaxation
c) It stimulates heart rate, contractility and cardiac output
d) It is used in the therapy of asthma
a) It acts primarily through the release of stored cathecholamines
b) It is a mild CNS stimulant
c) It causes tachyphylaxis with repeated administration
d) It decreases arterial pressure
a) Miosis
b) Bronchodilation
c) Hypotension
d) Bradycardia
a) It is a direct-acting sympathomimetic
b) It has oral activity
c) It is resistant to MAO and has much longer duration of action
d) Its effects are similar, but it is less potent
a) Epinephrine
b) Norepinephrine
c) Ephedrine
d) Salmeterol
a) Xylometazoline
b) Ephedrine
c) Terbutaline
d) Phenylephrine
a) Epinephrine
b) Dobutamine
c) Isoproterenol
d) Methoxamine
nerve block:
a) Epinephrine
b) Xylometazoline
c) Isoproterenol
d) Dobutamine
a) Xylometazoline
b) Terbutaline
c) Phenylephrine
d) Norepinephrine
a) Epinephrine
b) Norepinephrine
c) Phenylephrine
d) Xylometazoline
a) Phenylephrine
b) Xylometazoline
c) Ephedrine
d) Epinephrine
a) Methoxamine
b) Phenylephrine
c) Epinephrine
d) Xylometazoline
a) Formoterol
b) Norepinephrine
c) Methoxamine
d) Dobutamine
a) Methoxamine
b) Terbutaline
c) Norepinephrine
d) Epinephrine
a) Salmeterol
b) Phenylephrine
c) Dobutamine
d) Norepinephrine
a) Drug-induced parkinsonism
b) Cerebral hemorrhage or pulmonary edema
c) Myocardial infarction
d) Ventricular arrhythmias